Healthy men test drug interactions for MS treatment
NCT ID NCT06064539
First seen Nov 01, 2025 · Last updated May 15, 2026 · Updated 26 times
Summary
This study looked at how two common drugs, gemfibrozil and rifampicin, change the way the body processes a multiple sclerosis medicine called SAR442168. Thirty healthy men aged 18 to 45 took part. The goal was to gather information, not to treat any disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIPLE SCLEROSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Prism Research-Site Number:8400001
Saint Paul, Minnesota, 55144, United States
Conditions
Explore the condition pages connected to this study.